<DOC>
	<DOC>NCT00754819</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of colchicine on high sensitivity C-reactive protein (hs-CRP), a blood marker to measure inflammation, in patients with acute coronary syndromes.</brief_summary>
	<brief_title>Targeting Inflammation in Acute Coronary Syndrome Using Colchicine</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>All patients with a diagnosis of acute coronary syndrome who are &gt; 18 years old and who do not have any contraindication to colchicine. Contraindication to colchicine including any of the following: hypersensitivity to colchicine severe renal, hepatic or gastrointestinal disorder blood dyscrasias (myelodysplasia cytopenias etc) Concurrent use of moderatestrong CYP3A4 inhibitors (a complete list is appended in the full protocol) Known severe liver disease and/or elevated transaminases &gt; 1.5x the upper limit of normal Estimated GFR &lt; 50 ml/min Pregnant or lactating women or women not protected by a reliable contraception method Current treatment with colchicine at enrollment Active infection or systemic inflammation eg active rheumatoid arthritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>